Stockreport

INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023) [Yahoo! Finance]

INmune Bio Inc. - Common stock  (INMB) 
PDF All figures shown in the chart above are for the trailing 12 month (TTM) period Looking ahead, revenue is forecast to grow 85% p.a. on average during the next 3 years [Read more]